Patent Status
Original Provisional application 61/967,394 was filed in March 2014
Additional provisional filings were applied for in Nov. 2016 (62/42,714) and Nov. 2017 (62/583,679)
A CIP (Continuation in part ) was filed and publicized in April 2019
The publication also granted ELG access to the European markets
United States Patent Approved (Patent Number 11,089,979)
Clinical Testing Protocol
Clinical testing site (Rouse Family Medical Clinic, AR)
Test Subjects:
25 – 65 years old
Type 1 & 2 fasting and non fasting Glucose
100 test subjects
light, dark skin tone
Test Process:
ELG Device results compared to OTC Glucose testing kits
Blood draw results certified from labcorp
Test Goals:
Generate regression curves based on Bland-Altman plot
Calibrate algorithm if necessary
CONTACT US: https://parrotfish-bumblebee-tlg4.squarespace.com/contact
Business Development & Commercialization Goals
Licensing agreement
Future collaboration with established Medical Device companies such as Dexcom, Medtronic, Abbott, etc.
Distribution
Medical Surgical suppliers such as McKesson, Medline, Cardinal Health, J & J, etc.
Retail to Consumer – Amazon, Walmart, Target
Pharmacy chains
Walgreens, CVS, Rite Aid